SCM
PLXP

Stonepine Capital Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Stonepine Capital Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-506,274
Closed -$4.57M – 31
2021
Q1 		$4.57M Buy
+506,274
New +$3.7M 2.47% 14

Other funds holding PLXP

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Stonepine Capital Management's PLXP Position: Q2 2021 in Review

Stonepine Capital Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2021, closing a stake of 506,274 shares — an estimated $4.57M sold.

Stonepine Capital Management first reported a position in PLXP in Q1 2021 and held it in 1 quarter. The position peaked at $4.57M in Q1 2021. 46 funds tracked by Wall St. Rank hold PLXP as of Q2 2021.

  • Stonepine Capital Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Stonepine Capital Management sold 506,274 PLx Pharma Inc. Common Stock shares in Q2 2021, an estimated $4.57M.
  • Stonepine Capital Management first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Stonepine Capital Management's PLx Pharma Inc. Common Stock position peaked at $4.57M in Q1 2021.
  • 46 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2021.

Based on Stonepine Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.